| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.spandiag.com | |
| Market Cap | 7.82 Cr. | |
| Enterprise Value(EV) | 17.23 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -6.32 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 47.25 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | -5.39 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | -2.66 | Calculated using Price: 14.31 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.55 Cr. | 5,461,747 Shares |
| FaceValue | 10 | |
| About Span Divergent Ltd. | ||
| A thought, conceived more than three decades ago by a pathologist, Dr. Pradip K. Desai, evolved into a start-up company as the Desai Laboratories. The goal was to indigenously develop and manufacture a comprehensive range of ready-made diagnostic reagents needed by clinical pathology laboratories. In 1976, the company was reorganized as Span Diagnostics with an emphasis on in-house R & D to develop more and more products, keeping the customer needs in focus and quality under constant vigil. | ||
| 1 Day |
|
-4.66% |
| 1 Week |
|
-6.65% |
| 1 Month |
|
-17.62% |
| 3 Month |
|
-5.67% |
| 6 Month |
|
-10.17% |
| 1 Year |
|
-8.56% |
| 2 Year |
|
+5.53% |
| 5 Year |
|
-49.61% |
| 10 Year |
|
-61.32% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 92.48 | 5.87 | -5.29 | -29.53 | -45.78 | -40.14 | -41.61 | -142.6 | 0 | |
| Return on Capital Employed (%) | 80.49 | 8.14 | -4.08 | -17.56 | -21.68 | -17.85 | -14.67 | -44.86 | -43.9 | |
| Return on Assets (%) | 50.2 | 5.63 | -4.53 | -19.54 | -24.98 | -19.44 | -16.73 | -32.78 | -20.51 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 62 | 50 | 49 | 36 | 25 | 18 | 12 | 2 | -3 | -3 | |
| Non Curr. Liab. | 0 | 0 | 7 | 9 | 8 | 11 | 13 | 7 | 6 | 5 | |
| Curr. Liab. | 4 | 0 | 9 | 18 | 19 | 15 | 14 | 23 | 28 | 28 | |
| Minority Int. | 0 | 0 | -3 | -4 | -5 | -5 | -6 | -6 | |||
| Equity & Liab. | 66 | 51 | 65 | 63 | 49 | 39 | 34 | 28 | 25 | 24 | |
| Non Curr. Assets | 12 | 13 | 28 | 27 | 24 | 21 | 18 | 16 | 14 | 12 | |
| Curr. Assets | 54 | 38 | 37 | 36 | 25 | 18 | 16 | 12 | 12 | 12 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 66 | 51 | 65 | 63 | 49 | 39 | 34 | 28 | 25 | 24 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 76 | 3 | 15 | 24 | 9 | 7 | 13 | 13 | 13 | ||
| Other Income | 2 | 3 | 4 | 3 | 1 | 2 | 2 | 3 | 1 | 1 | |
| Total Income | 78 | 3 | 7 | 18 | 25 | 12 | 9 | 16 | 13 | 14 | |
| Total Expenditure | -74 | -5 | -8 | -25 | -31 | -15 | -10 | -14 | -11 | -12 | |
| PBIDT | 3 | -3 | -1 | -7 | -6 | -3 | 0 | 2 | 2 | 2 | |
| Interest | -4 | 0 | 0 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | |
| Depreciation | -6 | 0 | -1 | -3 | -4 | -3 | -3 | -2 | -2 | -2 | |
| Taxation | -6 | -1 | 0 | 0 | -1 | 1 | 0 | 0 | 0 | 0 | |
| Exceptional Items | 52 | 7 | -1 | -2 | -1 | -1 | -9 | -4 | -3 | ||
| PAT | 39 | 3 | -3 | -13 | -14 | -9 | -6 | -10 | -5 | -4 | |
| Minority Interest | 0 | 2 | 1 | 1 | 0 | 0 | 0 | ||||
| Share Associate | |||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 39 | 3 | -3 | -13 | -12 | -8 | -6 | -10 | -5 | -3 | |
| Adjusted EPS | 54 | 6 | -5 | -23 | -22 | -14 | -10 | -18 | -9 | -6 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 8 | 61 | -7 | -5 | -12 | -7 | 0 | 0 | 7 | 2 | |
| Cash Fr. Inv. | -5 | -12 | 13 | -6 | 1 | 10 | 6 | 2 | -2 | 1 | |
| Cash Fr. Finan. | -4 | -42 | -12 | 13 | 7 | -3 | -7 | -1 | -6 | -2 | |
| Net Change | 0 | 7 | -6 | 2 | -4 | 0 | -2 | 0 | -1 | 0 | |
| Cash & Cash Eqvt | 1 | 8 | 2 | 5 | 2 | 2 | 0 | 1 | 0 | 0 |
|
Thu, 25 Apr 2024
Span Divergent Limited - PCS Certificate For Transfer / Transmission / Transposition For The Year Ended On March 31 2024 Span Divergent Limited - PCS Certificate for Transfer / Transmission / Transposition for the year ended on March 31 2024 |
|
Tue, 23 Apr 2024
Span Divergent Limited - Compliance Certificate Pursuant To Regulation 7(3) For The Year Ended On March 31 2024 Span Divergent Limited - Compliance Certificate pursuant to Regulation 7(3) for the year ended on March 31 2024 |
|
Sun, 14 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Span Divergent Limited - Certificate under Reg 74(5) of SEBI (DP) Regulations 2018 |
| Fri, 26 Apr 2024 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
